Grown Rogue International (GRIN) Company presentation summary
Event summary combining transcript, slides, and related documents.
Company presentation summary
12 May, 2026Operating legacy and market presence
Ten-year track record built on quality, consistency, and culture, with roots in Southern Oregon and expansion into Michigan, New Jersey, Minnesota, and Illinois.
Proven ability to replicate performance and maintain durable quality control and cost efficiencies across facilities and markets.
Facilities include indoor and outdoor canopy in five states, with significant expansion underway in Minnesota and Illinois.
Financial performance and metrics
Q1 2026 revenue reached $9.2M, up 28% year-over-year, with adjusted EBITDA of $1.6M and a net cash position of $1.0M.
New Jersey operations contributed $2.5M in revenue and $1.5M in adjusted EBITDA in Q1 2026.
LTM revenue as of March 31, 2026, was $34.4M, with LTM adjusted EBITDA of $5.8M.
Industry landscape and regulatory environment
Cannabis remains federally illegal in the U.S., with state-by-state regulations and no interstate commerce.
Recent federal rescheduling reforms for medical cannabis may reduce tax friction and improve cash flow for qualifying operators.
The total U.S. cannabis market is estimated at $75B for 2025, with $31.6B in regulated sales and $43.1B in illicit sales.
Latest events from Grown Rogue International
- Q1 2026 revenue up 28% YoY to $9.2M; guidance raised as expansion and tech upgrades drive growth.GRIN
Q1 202613 May 2026 - Q2 2025 saw 4% pro forma revenue growth, margin pressure, and ongoing expansion efforts.GRIN
Q2 202522 Apr 2026 - 2025 revenue rose 22% to $32.4M, with strong growth and expansion set for 2026.GRIN
Q4 20257 Apr 2026 - Pro Forma Revenue up 26% year-over-year, driven by yield gains and new market expansion.GRIN
Q3 202517 Nov 2025 - Record revenue and aEBITDA growth, with expansion into New Jersey and Illinois underway.GRIN
Q2 202420 Aug 2025 - Q3 2024 revenue up 7% to $7.0M; New Jersey operations launched; Michigan margins improved.GRIN
Q3 202420 Aug 2025 - 2024 revenue rose 16% to $27.0M, with adjusted EBITDA up 27% and rapid New Jersey expansion.GRIN
Q4 202420 Aug 2025 - Expanding multi-state cannabis producer delivers strong growth, efficiency, and brand loyalty.GRIN
Investor Presentation20 Aug 2025 - Revenue up 7% year-over-year, but Adjusted EBITDA down 31% due to pricing pressure.GRIN
Q1 202520 Aug 2025